All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...788Next →

hiv & aids news selected from other sources

  • Mental and emotional health
    Patients with severe mental illnesses slip between cracks in HIV testing
    Medical Xpress | 11 hours ago

    People with bipolar disorder, schizophrenia and major depression with psychosis may be up to 15 more likely than the general population to be HIV positive, but are only marginally more likely to be tested for the virus, according to a study headed by UC San Francisco.

  • Pharmaceutical industry
    From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine
    NPR | 16 hours ago

    The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors' practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention and even oncologists on Twitter, according to a series of papers on money and influence published Tuesday in JAMA Internal Medicine.

  • Immunisations
    AT LAST: Gay men and transgender people get vaccine to prevent genital warts and anal cancer – impressive pilot results in England
    HIV i-Base | 16 hours ago

    Gay men and transgender people in England now have limited access to the HPV vaccine. Early results from an ongoing pilot study are extremely encouraging.

  • PrEP
    Press Ban at National PrEP Summit Was a Bad Idea for HIV Community
    The Body | 16 hours ago

    The National Minority AIDS Council banned press from its National PrEP Summit in December. At a time when we need more press focus on HIV prevention methods and the systemic barriers preventing those methods from getting the people who need them most, NMAC's decision is the wrong one.

  • PrEP
    New HIV prevention treatment can only work if perception improves
    De Montfort University (press release) | 16 hours ago

    A De Montfort University Leicester (DMU) professor and his PhD student have urged the medical profession and media to change the way in which a new HIV prevention treatment is represented if they want it to work. He found that men who would benefit most from taking PrEP were being put off by its association with “high risk” people – as they did not want to place themselves in this category.

  • PrEP
    PrEP HIV prevention drug trial expanded in Victoria but fears people still missing out
    ABC Online | 16 hours ago

    The Victorian AIDS Council (VAC) said 2,600 places in the Victorian trial were exhausted within about six months of opening last July. The organisation funded the trial along with the State Government and Alfred Health and this week allocated another $100,000 to allow a further 600 people to take part. But the existing waiting list already has about 550 people on it, and the Federal Government has been urged to support greater access to the drug across Australia.

  • Hepatitis C treatment
    Japan: Hepatitis C drug fakes found in Nara drugstore chain
    The Japan Times | 17 hours ago

    Counterfeits of the hepatitis C drug Harvoni have been found at a drugstore chain in Nara Prefecture, the health ministry said Tuesday. Harvoni is sold by a Japanese unit of U.S. pharmaceutical firm Gilead Sciences Inc. The ingredients of the counterfeits are now under examination.

  • Vaccines
    Successful antibody trial in HIV-infected individuals
    Eurekalert Inf Dis | 17 January 2017

    A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research, has tested a new HIV neutralizing antibody, called 10-1074, in humans. The results of the trial have just been published in Nature Medicine.

  • The search for a cure
    Turning “off” these 3 genes would protect T cells from HIV
    BETA blog | 17 January 2017

    A team of researchers at the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT And Harvard have recently identified human genes that could be the key to a gene therapy-based HIV treatment.

  • Global health initiatives
    Tragedy Would Unfold If Trump Cancels Bush’s AIDS Program
    The Atlantic | 17 January 2017

    A questionnaire from the president-elect’s transition team asked whether the extraordinarily successful PEPFAR had become a “massive, international entitlement program,” and whether it was worth the investment.

← First12345...1273Next →

Conference news

Latest news from The Liver Meeting.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.